Literature DB >> 14224647

STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.

E KOWALSKI, A Z BUDZYNSKI, M KOPEC, Z S LATALLO, B LIPINSKI, Z WEGRZYNOWICZ.   

Abstract

Entities:  

Keywords:  AMINOCAPROIC ACID; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; DOGS; EXPERIMENTAL LAB STUDY; FIBRINOGEN; FIBRINOLYSIN; HEMORRHAGE; PHARMACOLOGY; PROTAMINES; STREPTODORNASE AND STREPTOKINASE; TRYPSIN INHIBITORS

Mesh：

Substances：

Year:  1964        PMID： 14224647

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN： 0340-5338


× No keyword cloud information.
  7 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Fibrin degradation products in normal and abnormal pregnancy and parturition.

Authors:  J Bonnar; J F Davidson; C F Pidgeon; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1969-07-19

3.  Blood coagulation factor activity in experimental endotoxemia.

Authors:  R L West; M J Elovitz; R M Hardaway
Journal:  Ann Surg       Date:  1966-04       Impact factor: 12.969

4.  Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.

Authors:  S Niewiarowski; A F Senyi; P Gillies
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

Review 5.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Fibrin-fibrinogen degradation products in sera of normal infants and children.

Authors:  W S Uttley; A G Allan; J D Cash
Journal:  Arch Dis Child       Date:  1969-12       Impact factor: 3.791

7.  Fibrin Strands Will Grow from Soluble Fibrin and Hang Up in an In Vitro Microcirculatory Viscoelastic Model: Is This a Major Cause of COVID-19 Associated Coagulopathy?

Authors:  Brian S Bull; Karen L Hay; Paul C Herrmann
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.964
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.